Accufine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.60 Cr
as on 16-11-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.70 Cr
as on 16-11-2024
- Revenue -99.48%
(FY 2023)
- Profit -123.17%
(FY 2023)
- Ebitda -153.63%
(FY 2023)
- Net Worth -8.36%
(FY 2023)
- Total Assets -6.60%
(FY 2023)
About Accufine Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.60 Cr.
The company has closed loans amounting to ₹3.70 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Raxit Patel and Jigna Patel serve as directors at the Company.
- CIN/LLPIN
U24297GJ2018PTC103692
- Company No.
103692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2018
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Social Media
Who are the key members and board of directors at Accufine Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raxit Patel  | Director | 11-Nov-2020 | Current |
| Jigna Patel | Director | 06-Sep-2021 | Current |
Financial Performance of Accufine Pharmaceuticals.
Accufine Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.48% decrease. The company also saw a substantial fall in profitability, with a 123.17% decrease in profit. The company's net worth dipped by a decrease of 8.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accufine Pharmaceuticals?
In 2023, Accufine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 06 Aug 2019 | ₹3.70 Cr | Satisfied |
How Many Employees Work at Accufine Pharmaceuticals?
Unlock and access historical data on people associated with Accufine Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accufine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accufine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
